fate stock price target

128 rows This price target is based on 9 analysts offering 12 month price targets for Fate. According to the issued ratings of 10 analysts in the last year the consensus rating for Fate Therapeutics stock is Buy based on the current 2 hold ratings and 8 buy ratings for FATE.

Fate Therapeutics Nasdaqgm Fate Share Price News Analysis Simply Wall St

Ad How this fund has thrived as the market tanked.

. Find real-time FATE - Fate Therapeutics Inc stock quotes company profile news and forecasts from CNN Business. On average they predict Fate Therapeutics stock price to reach 8036 in the next year. FATE stock price news historical charts analyst ratings and financial information from WSJ.

In-depth view of key statistics and finances for FATE THERAPEUTICS INC. Evolution of the average Target Price on FATE THERAPEUTICS INC. The huge jump came after the biotech announced positive interim data from an.

11 Wall Street analysts have issued twelve-month target prices for Fate Therapeutics stock. --Baird Starts Fate Therapeutics at Neutral With 28 Price Target. 5 Wall Street analysts that have issued a 1 year FATE price target the average FATE price target is 8720 with the highest FATE stock price forecast at 11500 and the lowest FATE stock price forecast at 4500.

9189 Spread Average Target. For the coming years our community has positive and negative things to. This suggests a possible upside of 2398 from the stocks current price.

May 27 2022. FATE is higher by 060 from the previous closing price of 5876 on volume of 809593 shares. Piper Sandler Lowers Fate Therapeutics Price Target to 71 From 113 Maintains Overweight Rating.

Find out what this means to you and get the rest of the rankings on FATE. 47 rows Close price at the end of the last trading day Friday 20th May 2022 of the FATE stock was 2310. CRISPR Xencor stock falls as Piper Sandler slashes price target in biotech space.

TGTX analyst stock forecast price target and recommendation trends with in-depth analysis from research reports. The average price target is 000 with a high estimate. View analysts price targets for Fate.

The average price target represents a 21930 change from the last price of 2358. Their forecasts range from 2800 to 11600. FATE on MSN Money.

During the day the stock fluctuated 1137 from a. Ad Take Your Options Trading to the Next Level with Innovative Tools Educational Resources. Which would more than double the current price.

Fate Therapeutics Incs stock price has changed by -1979 over the past week -4096 over the past month and -6983. What happenedShares of Fate Therapeutics NASDAQ. Based on the current price of 2047 the target price of 8500 shows a potential of 315242 for Fate Therapeutics Inc.

The average twelve-month price target for Fate Therapeutics is 8560 with a high price target of 11600 and a low price target of 6000. The stock is down 5958. FATE stock quote history news and other vital information to help you with your stock trading and investing.

View the latest Fate Therapeutics Inc. 13500 Spread Highest target. FATE were skyrocketing 473 higher as of 1143 am.

Based On Fundamental Analysis. 21930 Upside Based on 9 Wall Street analysts offering 12 month price targets for Fate Therapeutics in the last 3 months. High Price Target.

Common Stock FATE at. Find the latest Fate Therapeutics Inc FATE stock price forecast 12-month price target predictions and analyst recommendations. Ad Our Strong Buys Double the SP.

Find the latest TG Therapeutics Inc. Competitors Todays change Todays. A fund that performs well in all market environments.

Become a member for free. Fate Therapeutics Inc FATE stock has gained 102 while the SP 500 is lower by -166 as of 130 PM on Monday Dec 20. This is 313 more than the trading day before Thursday 19th May 2022.

The average price target is 7529 with a high forecast of 11500 and a low forecast of 4500. Over the past year the SP 500 has risen 2298 while FATE is lower by -3689. Fate Therapeutics Inc NASDAQFATE is active in pre-market trading today June 6 with shares up 533 from the last closing price.

The average price target for FATE is 80214 and analysts rate the stock as a Strong Buy Wall Street analysts are rating FATE a Strong Buy today. Stock Target Advisors own stock analysis of Fate Therapeutics Inc is Slightly Bearish which is based on 3 positive signals and 4 negative signals. At the last closing Fate Therapeutics Incs stock price was USD 2181.

Analyst Price Target on FATE. Find the latest analyst research for Fate Therapeutics Inc. Find the latest Fate Therapeutics Inc.

Fate Fate Therapeutics Inc Stock Overview U S Nasdaq Barron S